Literature DB >> 20577937

Cerebrovascular complications in patients with cancer.

Lisa R Rogers1.   

Abstract

Stroke in the cancer patient is often caused by disorders of coagulation that are induced by the cancer, by cancer metastatic to the central nervous system, or by coagulation disorders or vascular injury due to cancer therapy. Nonbacterial thrombotic endocarditis in association with diffuse thrombosis of cerebral vessels is often the cause of cerebral infarction. Venous occlusion is most common in leukemic patients, but can also result from growth of solid tumor in the adjacent skull or dura. Chemotherapy administration is associated with a small risk of cerebral arterial or venous thrombosis. Radiation that is administered to the neck can result in delayed carotid atherosclerosis. Tumor embolization to the brain is a rare cause of stroke. Fungal septic cerebral emboli occur most commonly in leukemic patients who have undergone bone marrow transplantation. Hemorrhages occur in the brain parenchyma or the subdural and subarachnoid spaces and are most commonly caused by acute disseminated intravascular coagulation or metastatic tumor. Hemolysis from chemotherapy administration is a rare cause of brain hemorrhage. Careful clinical assessment, neuroimaging studies, measurement of coagulation function, and echocardiography are the most useful modalities to identify the cause of stroke. Thieme Medical Publishers.

Entities:  

Mesh:

Year:  2010        PMID: 20577937     DOI: 10.1055/s-0030-1255224

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  30 in total

1.  Recurrent thromboembolic events after ischemic stroke in patients with cancer.

Authors:  Babak B Navi; Samuel Singer; Alexander E Merkler; Natalie T Cheng; Jacqueline B Stone; Hooman Kamel; Costantino Iadecola; Mitchell S V Elkind; Lisa M DeAngelis
Journal:  Neurology       Date:  2014-05-21       Impact factor: 9.910

2.  When and why is surgical revascularization indicated for the treatment of moyamoya syndrome in patients with RASopathies? A systematic review of the literature and a single institute experience.

Authors:  Marcello Scala; Pietro Fiaschi; Valeria Capra; Maria Luisa Garrè; Domenico Tortora; Marcello Ravegnani; Marco Pavanello
Journal:  Childs Nerv Syst       Date:  2018-05-24       Impact factor: 1.475

Review 3.  Cancer and Cerebrovascular Disease.

Authors:  Harold P Adams
Journal:  Curr Neurol Neurosci Rep       Date:  2019-08-23       Impact factor: 5.081

4.  Clinical features of subarachnoid hemorrhage in patients with positive cancer history.

Authors:  Ichiyo Shibahara; Takashi Watanabe; Masayuki Ezura; Takashi Inoue; Miki Fujimura; Naoto Kimura; Tomoo Inoue; Ichiro Suzuki; Akiko Nishino; Shinjitsu Nishimura; Hiroshi Uenohara; Teiji Tominaga
Journal:  J Neurooncol       Date:  2016-02-20       Impact factor: 4.130

5.  Spontaneous intracranial haemorrhage in critically ill patients with malignancies.

Authors:  Jeong-Am Ryu; Daesang Lee; Jeong Hoon Yang; Chi-Ryang Chung; Chi-Min Park; Gee Young Suh; Kyeongman Jeon
Journal:  Support Care Cancer       Date:  2016-02-11       Impact factor: 3.603

6.  Cryptogenic subtype predicts reduced survival among cancer patients with ischemic stroke.

Authors:  Babak B Navi; Samuel Singer; Alexander E Merkler; Natalie T Cheng; Jacqueline B Stone; Hooman Kamel; Costantino Iadecola; Mitchell S V Elkind; Lisa M DeAngelis
Journal:  Stroke       Date:  2014-07-03       Impact factor: 7.914

7.  Stroke and Cancer- A Complicated Relationship.

Authors:  Jennifer L Dearborn; Victor C Urrutia; Steven R Zeiler
Journal:  J Neurol Transl Neurosci       Date:  2014

8.  Management of glioblastoma in an NF1 patient with moyamoya syndrome: a case report.

Authors:  Hideyuki Arita; Yoshitaka Narita; Makoto Ohno; Yasuji Miyakita; Yoshiko Okita; Takafumi Ide; Soichiro Shibui
Journal:  Childs Nerv Syst       Date:  2012-10-30       Impact factor: 1.475

Review 9.  Vascular Toxicities of Cancer Therapies: The Old and the New--An Evolving Avenue.

Authors:  Joerg Herrmann; Eric H Yang; Cezar A Iliescu; Mehmet Cilingiroglu; Konstantinos Charitakis; Abdul Hakeem; Konstantinos Toutouzas; Massoud A Leesar; Cindy L Grines; Konstantinos Marmagkiolis
Journal:  Circulation       Date:  2016-03-29       Impact factor: 29.690

10.  Ischaemic stroke as initial presentation of systemic malignancy.

Authors:  Stephan Goedee; Alike Naber; Jörgen M P Rovers; Gerwin Roks
Journal:  BMJ Case Rep       Date:  2014-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.